Sunshine Biopharma Inc. (SBFM)
NASDAQ · Healthcare
Sunshine Biopharma Inc. Shareholder Equity 2017–2025
Sunshine Biopharma Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Sunshine Biopharma Inc. shareholder equity as of December 31, 2025: 23.0M, a 1.97% decrease year-over-year.
- Sunshine Biopharma Inc. shareholder equity for 2025 were 23.0M, a 1.97% decrease from 2024.
- Sunshine Biopharma Inc. shareholder equity for 2024 were 23.5M, a 10.81% increase from 2023.
- Sunshine Biopharma Inc. shareholder equity for 2023 were 21.2M, a 1.94% decrease from 2022.
- Sunshine Biopharma Inc. shareholder equity for 2022 were 21.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Sunshine Biopharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $23 |
| 2024 | $24 |
| 2023 | $21 |
| 2022 | $22 |
| 2021 | $0 |
| 2020 | $-1 |
| 2019 | $-1 |
| 2018 | $-0 |
| 2017 | $-1 |
Sunshine Biopharma Inc. Shareholder Equity — FAQ
Sunshine Biopharma Inc. (SBFM) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SBFM's shareholder equity history?
The chart and table above show Sunshine Biopharma Inc.'s shareholder equity by year and by quarter, including the growth rate.